Emtricitabine and tenofovir disoproxil fumarate 200 mg/1

Emtricitabine and tenofovir disoproxil fumarate 200 mg/1 tablets are a combination medication used for HIV treatment. This oral medication helps manage HIV infection by reducing viral load and improving immune function.

Emtricitabine and tenofovir disoproxil fumarate 200 mg/1 tablets are primarily used in the treatment of HIV-1 infection. This combination therapy is designed to reduce the amount of HIV in the body, which helps to improve immune function and slow the progression of the disease. The medication is often used as part of a broader antiretroviral therapy regimen.

Common effects of emtricitabine and tenofovir disoproxil fumarate 200 mg/1 tablets may include headaches, nausea, and diarrhea. Some individuals may also experience dizziness, fatigue, or changes in mood. These effects can vary from person to person and may not affect everyone who takes the medication.

Emtricitabine and tenofovir disoproxil fumarate 200 mg/1 tablets should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature, away from moisture and heat. Always consult a healthcare provider before starting or stopping any medication.

Emtricitabine and tenofovir disoproxil fumarate 200 mg/1 tablets may interact with other medications, including certain antibiotics, antifungals, and anticonvulsants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the medication.